Citations

Mayo Clinic

Showing 10 of 108523 citations.

A Dark-Brown Serum Sample
Wittwer, Craig A., Baumann, N, Block, Darci R , Willrich, Maria A V, Baumann, Nikola A, Willrich, Maria Alice V.

Clinical Chemistry | June 26, 2015 | Volume: 61 | Issue: 7 | Pages: 999-1000

10.1373/clinchem.2015.238493 | PMID 26116641 Get It

Invertible Micellar Polymer Nanoassemblies Target Bone Tumor Cells But Not Normal Osteoblast Cells
Kudina, Olena , Shogren, Kristen L., Gustafson, Carl T., Yaszemski, Michael J. , Maran, Avudaiappan , Voronov, Andriy S.

Future Science OA | June 26, 2015 | Volume: 1 | Issue: 3 | Pages: No page available

10.4155/fso.15.14 | PMID 28031891 Get It

Commentary
Nichols, William L.

Clinical Chemistry | June 26, 2015 | Volume: 61 | Issue: 7 | Pages: 913-913

10.1373/clinchem.2014.232819 | PMID 26116640 Get It

Diabetic Nephropathy and CKD—Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and Prediction
Onuigbo, Macaulay , Agbasi, Nneoma, Onuigbo, Macaulay Amechi Chukwukadibia

Journal of Clinical Medicine | June 26, 2015 | Volume: 4 | Issue: 7 | Pages: 1348-1368

10.3390/jcm4071348 | PMID 26239680 Get It

Creatinine is produced in muscle metabolism as the end-product of creatine phosphate and is subsequently excreted principally by way of the kidneys, predominantly by glomerular filtration. Blood creatinine assays constitute the most common clinically relevant measure of renal function. The use of individual patient-level real-time serum creatinine trajectories provides a very attractive and tantalizing methodology in nephrology practice. Topics covered in this review include acute kidney injury (AKI) with its multifarious rainbow spectrum of renal outcomes; the stimulating vicissitudes of the diverse patterns of chronic kidney disease (CKD) to end-stage renal disease (ESRD) progression, including the syndrome of rapid onset end stage renal disease (SORO-ESRD); the syndrome of late onset renal failure from angiotensin blockade (LORFFAB); and post-operative AKI linked with the role of intra-operative hypotension in patients with diabetes mellitus and suspected diabetic nephropathy with CKD. We conclude that the study of individual patient-level serum creatinine trajectories, albeit a neglected and forgotten diagnostic methodology for diabetic CKD prognostication and prediction, is a most useful diagnostic tool, both in the short-term and in the long-term practice of nephrology. The analysis of serum creatinine trajectories, both in real time and retrospectively, indeed provides supplementary superior diagnostic and prognostic insights in the management of the nephrology patient.
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder
Kemp, David E. , Friedman, Edward S., Reilly-Harrington, Noreen A. , Sylvia, Louisa G. , Calabrese, Joseph R. , Rabideau, Dustin J. , Ketter, Terence A. , Thase, Michael E., Tohen, Mauricio , Bowden, Charles L., Brody, Benjamin D. , Deckersbach, Thilo , Kocsis, James H., Kinrys, Gustavo , Kamali, Masoud , McInnis, Melvin G. , Leon, Andrew C. , Faraone, Stephen V. , Nierenberg, Andrew A. , Shelton, Richard C. , McElroy, Susan L. , Singh, Vivek Kumar , Bernstein, Emily E. , Bobo, William V. , Kamali, Masoud , McInnis, Melvin G

Acta Psychiatrica Scandinavica | June 26, 2015 | Volume: 133 | Issue: 2 | Pages: 144-153

10.1111/acps.12460 | PMID 26114830 Get It

ObjectiveExamine the effects of obesity and metabolic syndrome on outcome in bipolar disorder.MethodThe Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder (Bipolar CHOICE) study randomized 482 participants with bipolar disorder in a 6‐month trial comparing lithium‐ and quetiapine‐based treatment. Baseline variables were compared between groups with and without obesity, with and without abdominal obesity, and with and without metabolic syndrome respectively. The effects of baseline obesity, abdominal obesity, and metabolic syndrome on outcomes were examined using mixed effects linear regression models.ResultsAt baseline, 44.4% of participants had obesity, 48.0% had abdominal obesity, and 27.3% had metabolic syndrome; neither obesity, nor abdominal obesity, nor metabolic syndrome were associated with increased global severity, mood symptoms, or suicidality, or with poorer functioning or life satisfaction. Treatment groups did not differ on prevalence of obesity, abdominal obesity, or metabolic syndrome. By contrast, among the entire cohort, obesity was associated with less global improvement and less improvement in total mood and depressive symptoms, suicidality, functioning, and life satisfaction after 6 months of treatment. Abdominal obesity was associated with similar findings. Metabolic syndrome had no effect on outcome.ConclusionObesity and abdominal obesity, but not metabolic syndrome, were associated with less improvement after 6 months of lithium‐ or quetiapine‐based treatment.
Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice
Santhanam, Anantha Vijay R., d’Uscio, Livius V. , He, Tongrong , Das, Pritam , Younkin, Steven G. , Katušić, Zvonimir S.

Journal of Neurochemistry | June 26, 2015 | Volume: 134 | Issue: 6 | Pages: 1129-1138

10.1111/jnc.13205 | PMID 26111938 Get It

AbstractIn this study, we tested the hypothesis that reduced bioavailability of tetrahydrobiopterin (BH4) is a major mechanism responsible for pathogenesis of endothelial dysfunction in cerebral microvessels of transgenic mice expressing the Swedish double mutation of human amyloid precursor protein (APP) (Tg2576 mice). Endothelial nitric oxide synthase (eNOS) protein expression was significantly increased in cerebral vasculature of Tg2576 mice. In contrast, bioavailability of BH4 was significantly reduced (p < 0.05). Moreover, superoxide anion production was increased in cerebral microvessels of Tg2576 mice (p < 0.05). Incubation with NOS inhibitor, Nω‐nitro‐L‐arginine methyl ester, decreased superoxide anion indicating that uncoupled eNOS is most likely the source of superoxide anion. Increasing BH4 bioavailability either exogenously by BH4 supplementation or endogenously by treatment with the selective peroxisome proliferator‐activated receptor – delta activator GW501516 (2 mg/kg/day, 14 days) attenuated eNOS uncoupling and decreased superoxide anion production in cerebral microvessels of Tg2576 mice (p < 0.05). Treatment with GW501516 restored the biological activity of endothelial nitric oxide in cerebral microvessels of Tg2576 mice, as indicated by the increased nitrite/nitrate content and 3,5‐cyclic guanosine monophosphate levels (p < 0.05). Our studies indicate that sub‐optimal BH4 bioavailability in cerebral vasculature is an important contributor to oxidant stress and endothelial dysfunction in Tg2576 mouse model of Alzheimer's disease. imageExisting evidence suggests that Aβ peptides‐induced up‐regulation of expression and activity of NADPH oxidase causes increased production of superoxide anion (.O2−). .O2− can also be converted to hydrogen peroxide (H2O2) by enzymatic activity of superoxide dismutase (SOD) or spontaneous dismutation. Elevation of .O2− and H2O2 might cause oxidation of tetrahydrobiopterin (BH4) to dihydrobiopterin (BH2) and subsequent uncoupling of endothelial nitric oxide synthase (eNOS) (a) thus reducing levels of nitric oxide (NO) and 3′,5′‐cyclic guanosine monophosphate (cGMP). Supplementation of BH4 or activation of PPARδ prevents detrimental effects of eNOS uncoupling by restoring bioavailability of BH4 and scavenging of .O2−, respectively (b). Activation of PPARδ also increases expression of catalase thereby inactivating H2O2. Generation of H2O2 by uncoupled eNOS in cerebral microvessels of Tg2576 mice is hypothetical.
Evolution of optogenetic microdevices
Kale, Rajas P. , Berk, Michael , Tye, Susannah J. , Kouzani, Abbas Z. , Walder, Ken R. , Berk, Michael , Tye, Susannah J

Neurophotonics | June 26, 2015 | Volume: 2 | Issue: 3 | Pages: 031206

10.1117/1.nph.2.3.031206 | PMID 26158015 Get It

The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
Pastori, Chiara , Penas, Clara , Peschansky, Veronica J. , Volmar, Claude‐Henry , Bregy, Amadé , Komotar, Ricardo J. , Laurent, Georges St., Ayad, Nagi G. , Kapranov, Philipp , Sarkaria, Jann N. , Wahlestedt, Claes

Proceedings of the National Academy of Sciences | June 26, 2015 | Volume: 112 | Issue: 27 | Pages: 8326-8331

10.1073/pnas.1424220112 | PMID 26111795 Get It

Significance Glioblastoma Multiforme (GBM) is the most common and deadliest primary brain tumor in adults. As the median survival is approximately 14 mo there is an urgent need for novel therapies. Epigenetic modulators such as bromodomain and extraterminal (BET) proteins are important therapeutic targets in GBM. Bromodomain inhibitors (including I-BET151) suppress proliferation by repressing oncogenes and inducing tumor suppressor genes through unidentified pathways. Here we demonstrate that HOTAIR (HOX transcript antisense RNA) is overexpressed in GBM, where it is crucial to sustain tumor cell proliferation, and that inhibition of HOTAIR by I-BET151 is necessary to induce cell cycle arrest in GBM cells. Our study outlines the mechanism of action underlying the antiproliferative activity of I-BET151, showing for the first time, to our knowledge, that the oncogenic long noncoding RNA HOTAIR is a major target.
Shared Decision-making in the Emergency Department: Respecting Patient Autonomy When Seconds Count
Grudzen, Corita R. , Thomson, Richard, Carpenter, Christopher R. , Hess, Erik P. , Raja, Ali S , Carpenter, Christopher R

Academic Emergency Medicine | June 25, 2015 | Volume: 22 | Issue: 7 | Pages: 856-864

10.1111/acem.12703 | PMID 26112797 Get It

Reference values for jitter recorded by concentric needle electrodes in healthy controls: A multicenter study
Stålberg, Erik , Sanders, Donald B. , Cooray, Gerald , Leonardis, Lea , Løseth, Sissel , Machado, Flávia Costa Nunes , Martinez‐Aparicio, Carmen , Sandberg, Arne, Smith, Benn, Widenfalk, Johan, Kouyoumdjian, João Aris , Ali, Sajjad , Maldonado, Antonio , Smith, Benn E.

Muscle & Nerve | June 25, 2015 | Volume: 53 | Issue: 3 | Pages: 351-362

10.1002/mus.24750 | PMID 26112058 Get It

ABSTRACT Introduction: The aim of this study was to create reference values for jitter measured with concentric needle electrodes. Methods: Operators worldwide contributed recordings from orbicularis oculi (OO), frontalis (FR), and extensor digitorum (ED) muscles in healthy controls. Criteria for acceptable signal quality were agreed upon in advance. Fifteen or 20 recordings of acceptable quality from each muscle were required for voluntary and electrical stimulation recordings, respectively. Results: Recordings from 59 to 92 subjects were obtained for each muscle and activation type. Outlier limits for mean consecutive difference and individual jitter data for voluntary activation were: OO, 31 and 45 µs; FR, 28 and 38 µs; ED, 30 and 43 µs; and for electrical stimulation they were: OO, 27 and 36 µs; FR, 21 and 28 µs; ED, 24 and 35 µs. Conclusion: Reference jitter values from concentric needle electrode recordings were developed from signals of defined quality while seeking to avoid creating supernormal values. Muscle Nerve 53: 351–362, 2016